OCM
Osterweis Capital Management’s Amicus Therapeutics FOLD Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.44M | Sell |
250,935
-573,805
| -70% | -$3.29M | 0.07% | 100 |
|
2025
Q1 | $6.73M | Buy |
+824,740
| New | +$6.73M | 0.33% | 74 |
|
2024
Q4 | – | Sell |
-884,820
| Closed | -$9.45M | – | 202 |
|
2024
Q3 | $9.45M | Buy |
884,820
+195,395
| +28% | +$2.09M | 0.48% | 65 |
|
2024
Q2 | $6.84M | Buy |
689,425
+205,365
| +42% | +$2.04M | 0.35% | 74 |
|
2024
Q1 | $5.7M | Buy |
+484,060
| New | +$5.7M | 0.33% | 78 |
|
2020
Q2 | – | Sell |
-241,002
| Closed | -$2.23M | – | 117 |
|
2020
Q1 | $2.23M | Sell |
241,002
-290,280
| -55% | -$2.68M | 0.18% | 82 |
|
2019
Q4 | $5.18M | Buy |
531,282
+66,267
| +14% | +$645K | 0.36% | 61 |
|
2019
Q3 | $3.73M | Buy |
465,015
+60,235
| +15% | +$483K | 0.27% | 70 |
|
2019
Q2 | $5.05M | Sell |
404,780
-54,050
| -12% | -$675K | 0.36% | 59 |
|
2019
Q1 | $6.24M | Buy |
+458,830
| New | +$6.24M | 0.39% | 63 |
|